☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
topline results
Bone Therapeutics's JTA-004 Fails to Meet its All Endpoints in P-III Study for Knee Osteoarthritis
August 31, 2021
PharmaShots Interview: Tetra Therapeutics' Mark Gurney Shares Insight on Topline Results of BPN14770 for Fragile X Syndrome
March 1, 2021
Biogen and UCB Reports Results of Dapirolizumab Pegol (DZP) in A P-IIb study for Systemic Lupus Erythematosus (SLE)
October 23, 2018
Load more...
Back to Home
Modal title
×
Modal body text goes here.
